62398 Federal Register / Vol. 88, No. 174 / Monday, September 11, 2023 / Notices 

substance in schedule IV or V which is 

also listed in schedule I or II of the 

Convention on Psychotropic 

Substances, must have an import 

permit. To obtain the permit to import 

controlled substances for domestic and 

or scientific purposes, an application for 

the permit must be made to the DEA, on 

DEA Form 357. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a previously approved 

collection. 

2. The Title of the Form/Collection: 

Application for Permit to Import 

Controlled Substances for Domestic 

and/or Scientific Purposes. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

DEA Form 357. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Office of Diversion 

Control. 

4. Affected public who will be asked 

or required to respond, as well as the 

obligation to respond: Affected Public: 

Private Sector—businesses or other forprofit institutions. The obligation to 

respond is mandatory per 21 CFR, 

sections 1312.11, 1312.12 and 1312.13. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The DEA estimates that 124 

registrants participate in this 

information collection. The time per 

response is 21 minutes to complete the 

DEA–357 (paper) and 15 minutes to 

complete DEA–357 (online). 

6. An estimate of the total annual 

burden (in hours) associated with the 

collection: DEA estimates that this 

collection takes 264.35 annual burden 

hours. 

7. An estimate of the total annual cost 

burden associated with the collection, if 

applicable: $0. 

TOTAL BURDEN HOURS

Activity Number of 

respondents Frequency Total annual responses 

Time per 

response 

(min.) 

Total annual 

burden 

(hours) 

DEA Form: 357 (online) ....................................................... 124 9 958 15 266 

DEA Form: 357 (paper) ....................................................... 71 21 19 

Unduplicated Totals ...................................................... 124 ........................ 1,081 0.26 264.35 

If additional information is required 

contact: Darwin Arceo, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 4W–218, 

Washington, DC. 

Dated: September 5, 2023. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2023–19536 Filed 9–8–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0024] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Revision of a 

Previously Approved Collection; 

Report of Loss or Disappearance of 

Listed Chemicals and Regulated 

Transactions in Tableting/ 

Encapsulating Machines 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Drug Enforcement 

Administration (DEA), Department of 

Justice (DOJ), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until 

November 13, 2023. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Scott A Brinks, Regulatory Drafting and 

Policy Support Section, Drug 

Enforcement Administration; Mailing 

Address: 8701 Morrissette Drive, 

Springfield, Virginia 22152; Telephone: 

(571) 362–3261, Email: scott.a.brinks@

dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Bureau of Justice 

Statistics, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Abstract: Each regulated person is 

required to report any unusual or 

excessive loss or disappearance of a 

listed chemical, and any regulated 

transaction in a tableting or 

encapsulating machine, to include any 

domestic regulated transaction in a 

tableting or encapsulating machine and 

any import or export of a tableting or 

encapsulating machine. 21 U.S.C. 830 

(b)(1)(A), (C) and (D); 21 CFR 

1310.05(a)(1), (3)–(4); 21 CFR 

1310.05(c). Regulated persons include 

manufacturers, distributors, importers, 

and exporters of listed chemicals, 

tableting machines, or encapsulating 

machines, or persons who serve as 

brokers or traders for international 

transactions involving a listed chemical, 

tableting machine, or encapsulating 

machine. 21 CFR 1300.02(b). This report 

will be submitted electronically. DEA 

will be modifying this collection (1117– 

0024) and collection 1117–0001 by 

removing Form 107 from this collection 

and adding it to 1117–0001 because 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 174 / Monday, September 11, 2023 / Notices 62399 

DEA Form 107 is more aligned with 

DEA Form 106 (which is approved 

under 1117–0001). 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Revision of a previously approved 

collection. 

2. The Title of the Form/Collection: 

Report of Loss or Disappearance of 

Listed Chemicals and Regulated 

Transactions in Tableting/Encapsulating 

Machines. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

DEA Form 452. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Office of Diversion 

Control. 

4. Affected public who will be asked 

or required to respond, as well as the 

obligation to respond: Affected Public 

(Primary): Private Sector—businesses or 

other for-profit institutions, and not-forprofit institutions. Other: State, local 

and tribal governments, Federal 

Government. The obligation to respond 

is mandatory per 21 21 CFR 

1310.05(a)(1), (3)–(4); 21 CFR 

1310.05(c). 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: DEA estimates that 274 

persons respond as needed to this 

collection. Responses take 0.33 minutes. 

6. An estimate of the total annual 

burden (in hours) associated with the 

collection: DEA estimates that this 

collection takes 8,367 annual burden 

hours. 

7. An estimate of the total annual cost 

burden associated with the collection, if 

applicable: $0. 

TOTAL BURDEN HOURS

Activity Number of 

respondents Frequency Total annual responses 

Time per 

response 

(mins) 

Total annual 

burden 

(hours) 

DEA–452 .............................................................................. 274 92 25,208 .33 8,367 

Unduplicated Totals ...................................................... 274 ........................ 25,101 ........................ 8,367 

If additional information is required 

contact: Darwin Arceo, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 4W–218, 

Washington, DC. 

Dated: September 5, 2023. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2023–19538 Filed 9–8–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0004] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Extension of a 

Previously Approved Collection; 

Application for Permit To Export 

Controlled Substances, Application for 

Permit To Export Controlled 

Substances for Subsequent Reexport 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Drug Enforcement 

Administration (DEA), Department of 

Justice (DOJ), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until 

November 13, 2023. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Scott A. Brinks, Regulatory Drafting and 

Policy Support Section, Drug 

Enforcement Administration; Mailing 

Address: 8701 Morrissette Drive, 

Springfield, Virginia 22152; Telephone: 

(571) 362–3261, Email: scott.a.brinks@

dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Bureau of Justice 

Statistics, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Abstract: Title 21, Code of Federal 

Regulations (21 CFR), sections 1312.21 

and 1312.22 require that any person 

who desires to export or reexport 

controlled substances listed in 

schedules I or II, any narcotic substance 

listed in schedules III or IV, or any nonnarcotic substance in schedule III which 

the Administrator has specifically 

designated by regulation in section 

1312.30, or any non-narcotic substance 

in schedule IV or V which is also listed 

in schedule I or II of the Convention on 

Psychotropic Substances, must have an 

export permit. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a previously approved 

collection. 

2. The Title of the Form/Collection: 

Application for Permit to Export 

Controlled Substances, Application for 

Permit to Export Controlled Substances 

for Subsequent Reexport. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

DEA Forms: 161, 161R, and 161R–EEA. 

The applicable component within the 

Department of Justice is the Drug 


ddrumheller on DSK120RN23PROD with NOTICES1